Live Breaking News & Updates on Prnewswire Pharming Groupnv|Page 4

Stay updated with breaking news from Prnewswire pharming groupnv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pharming Group N.V.: Pharming Group issues statement regarding the events surrounding Silicon Valley Bank

LEIDEN, Netherlands, March 12, 2023 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company")( Euronext Amsterdam: PHARM) (Nasdaq: PHAR) is aware that the Federal Deposit Insurance Corporation ....

United States , United Kingdom , City Of , Noord Holland , Dennis Riedl , Heather Robertson , Michael Levitan , Silicon Valley Bank , Deposit Insurance Corporation , Vp Investor Relations Corporate Communications , Silicon Valley Bank United Kingdom Limited , Exchange Commission , Prnewswire Pharming Groupnv , Pharming Group , Lifespring Life Sciences Communication , Company Euronext Amsterdam , Investor Relations Corporate Communications , Euronext Amsterdam , Federal Deposit Insurance Corporation , North America , Middle East , Annual Report , Investor Relations , Corporate Communications , Spring Life Sciences Communication ,

Pharming Group N.V.: Notice of Full Year 2022 financial results

LEIDEN, Netherlands, Feb. 28, 2023 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) confirms it will announce its unaudited Full Year ....

United States , United Kingdom , City Of , Noord Holland , Dennis Riedl , Heather Robertson , Michael Levitan , Vp Investor Relations Corporate Communications , Exchange Commission , Prnewswire Pharming Groupnv , Pharming Group , Lifespring Life Sciences Communication , Investor Relations Corporate Communications , Full Year , North America , Middle East , Annual Report , Investor Relations , Corporate Communications , Spring Life Sciences Communication ,

Pharming Group N.V.: Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

The multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency LEIDEN, Netherlands, Feb. 21, 2023 /PRNewswire/ ....

United States , United Kingdom , City Of , Noord Holland , Manish Butte , Dennis Riedl , Ethan Metelenis , Heather Robertson , Michael Levitan , Dan Caley , Anurag Relan , E Richard Stiehm , Vp Investor Relations Corporate Communications , Drug Administration , Regulatory Agency , Exchange Commission , American Society Of Hematology , Prnewswire Pharming Groupnv , European Medicines Agency , Department Of Pediatrics , Pharming Group , Lifespring Life Sciences Communication , Committee For Medicinal Products Human Use , Investor Relations Corporate Communications , Stiehm Endowed Chair , Division Chief ,

Pharming announces first patient enrolled in pediatric clinical trial of leniolisib

/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR) announces that the first patient has been enrolled. ....

United States , United Kingdom , City Of , Noord Holland , Manish Butte , Ethan Metelenis , Heather Robertson , Michael Levitan , Dan Caley , Anurag Relan , E Richard Stiehm , Vp Investor Relations Corporate Communications , Drug Administration , Regulatory Agency , Exchange Commission , American Society Of Hematology , Prnewswire Pharming Groupnv , European Medicines Agency , Department Of Pediatrics , Pharming Group , Lifespring Life Sciences Communication , Committee For Medicinal Products Human Use , Investor Relations Corporate Communications , Stiehm Endowed Chair , Division Chief , American Society ,

Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe

/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces that the European Medicines Agency s. ....

United States , United Kingdom , City Of , Noord Holland , Ethan Metelenis , Heather Robertson , Michael Levitan , Dan Caley , Vp Investor Relations Corporate Communications , Committee For Human Medicinal Products , Exchange Commission , Prnewswire Pharming Groupnv , European Medicines Agency , Pharming Group , Lifespring Life Sciences Communication , Investor Relations Corporate Communications , Authorisation Application , Human Medicinal Products , Marketing Authorisation Application , European Economic , Activated Phosphoinositide , North America , Middle East , Annual Report , Allergy Clin , Rev Allergy ,